资讯

Health and Me on MSN3 小时
FDA Approves Once-Monthly Injection For Hereditary Angioedema; What It Means For Long-Term ...
The newly approved Andembry, a once-monthly self-injection for hereditary angioedema, offering over 99% attack reduction and ...
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing ...
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
This drug offers 99.9% protection against HIV, but there’s a catch
The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...